GE Capital of the American conglomerate General Electric (GE) will invest Rs.125 crore ($24 million) for a minority stake in the research arm of the country's biotech major Biocon Ltd. according to an official announcement. ‘GE Capital's Mauritius subsidiary (GE Equity International) will invest Rs.125 crore for a 7.69 percent equity share in our research services subsidiary Syngene International Ltd.’ Biocon chairperson Kiran Mazumdar Shaw told reporters here. Noting that the private equity investment would propel Syngene to go public soon Shaw said GE's decision validated the subsidiary's business model to deliver value to its partners and investors. ‘The investment will enable
